Bayer bets up to $100M on exploring new biomolecular condensate terrain with a biotech upstart

November 14th, 2019 | Endpoint News

In the Indiana Jones warehouse of genomic oddities, the millions of units of so-called “junk DNA” that create nothing but play a hand in tons of things have grabbed most of the attention. But there are other arks and Templar crosses out there…

Full article